Survival Prolongation by Rationale INnovative Genomics (SPRING): An international WIN Consortium Phase I/II proof-of-concept study to explore the safety and efficacy of a tri-therapy approach using avelumab, palbociclib and axitinib in advanced/metastatic non-small cell lung cancer (NSCLC) with integrated genomic and transcriptomic correlates

Benjamin Solomon, Enriqueta Felip, Jair Bar, Guy Berchem, Lyudmila Bazhenova, Pierre Saintigny, Nicolas Girard, Raed Sulaiman, Catherine Bresson, Fanny Wunder, J. Jack Lee, Jacques Raynaud, Eitan Rubin, Brandon Young, Vladimir Lazar, Amir Onn, Brian Leyland Jones, Razelle Kurzrock

Research output: Contribution to journalMeeting Abstractpeer-review

Original languageEnglish
Article number CT223
JournalCancer Research
Issue number13 Suppl.
Publication statusPublished - Jul 2019
EventAnnual Meeting of the American Association for Cancer Research (AACR) 2019 - Atlanta, United States
Duration: 29 Mar 20193 Apr 2019

Cite this